Location History:
- Vienna, AT (1992 - 1996)
- Purkersdorf, AT (2001 - 2004)
Company Filing History:
3 out of 1,537 
1 out of 306 
Years Active: 1992-2004
Title: Wolfgang Sommergruber: Innovator in Cancer Immunotherapy
Introduction
Wolfgang Sommergruber is a notable inventor based in Purkersdorf, Austria. He has made significant contributions to the field of immunotherapy, particularly in the development of tumor-associated antigens and methods for utilizing viral proteinases.
Latest Patents
Sommergruber holds 4 patents, with his latest innovations focusing on critical advancements in cancer treatment. One of his patents involves tumor-associated antigens, specifically the R11 antigen, which includes immunogenic peptides and DNA molecules that can be used in cancer immunotherapy. Another significant patent pertains to Picornavirus I proteinase, detailing methods for creating and utilizing Picornavirus L proteinase peptides. This includes the expression of DNA encoding these peptides and methods for identifying active sites and inhibitors.
Career Highlights
Throughout his career, Sommergruber has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Vetmedica GmbH. His work has been instrumental in advancing therapeutic strategies for various diseases.
Collaborations
Sommergruber has collaborated with esteemed colleagues in his field, including Dieter Blaas and Timothy Skern. Their joint efforts have contributed to the development of innovative solutions in immunotherapy.
Conclusion
Wolfgang Sommergruber's contributions to cancer immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in medical science and treatment options for cancer patients.